Relief Therapeutics EBITDA vs. Shares Owned By Institutions
| RLF Stock | CHF 3.90 0.08 2.01% |
For Relief Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Relief Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Relief Therapeutics Holding utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Relief Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Relief Therapeutics Holding over time as well as its relative position and ranking within its peers.
Relief |
Relief Therapeutics Shares Owned By Institutions vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Relief Therapeutics's current stock value. Our valuation model uses many indicators to compare Relief Therapeutics value to that of its competitors to determine the firm's financial worth. Relief Therapeutics Holding is rated fourth in ebitda category among its peers. It is rated third in shares owned by institutions category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Relief Therapeutics' earnings, one of the primary drivers of an investment's value.Relief Shares Owned By Institutions vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Relief Therapeutics |
| = | (33.3 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Relief Therapeutics |
| = | 22.16 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Relief Shares Owned By Institutions Comparison
Relief Therapeutics is currently under evaluation in shares owned by institutions category among its peers.
Relief Therapeutics Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Relief Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Relief Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Relief Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Relief Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people.
Relief Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Relief Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Relief Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Relief Therapeutics' important profitability drivers and their relationship over time.
Use Relief Therapeutics in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Relief Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will appreciate offsetting losses from the drop in the long position's value.Relief Therapeutics Pair Trading
Relief Therapeutics Holding Pair Trading Analysis
The ability to find closely correlated positions to Relief Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Relief Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Relief Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Relief Therapeutics Holding to buy it.
The correlation of Relief Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Relief Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Relief Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Relief Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Relief Therapeutics position
In addition to having Relief Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Government Funds Thematic Idea Now
Government Funds
Funds or Etfs that invest in fixed income securities issued by national government to finance government spending or to facilitate Federal Reserve monetary policies. The Government Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Government Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Relief Stock Analysis
When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.